Pharm Unit 3: Aspiration/PONV, Antiarrhythmics, Fluids, LA, Abx (FINAL) Flashcards
What types of drugs are used for aspiration prevention
H1 blockers
H2 blockers
PPI’s
Dopa receptor antagonists
H1 blockers MOA
decreased contraction of intestinal smooth muscle
H1 blockers uses
sedation
decreased GI motility
antimuscarinic
what is the H1 blocker
diphenhydramine
H2 blockers MOA
decrease acidity of gastric acid
H2 blockers uses
ulcers
GERD
H2 blockers common drugs
“tidine”
ranitidine
famotidine
nizatidine
cimetidine
PPI MOA
inhibit acid secretion
PPI uses
ulcers, GERD
PPI common drugs
“prazole”
pantoprazole
omeprazole
lansoprazole
dopamine receptor antagonist MOA
increase LES tone
increase GI motility
dopamine receptor antagonist uses
GERD
diabetic gastroparesis
dopamine receptor antagonist adverse effects
acute dystonic reaction
common dopamine receptor antagonist
metoclopramide
5HT3 antagonists MOA
block serotonin
- peripherally: vagal nerve terminals
- centrally: chemoreceptor trigger zone
5HT3 antagonists uses
emesis due to vagal stimulation
5HT3 antagonists adverse effects
QT prolongation
5HT3 antagonists contraindications
pts w/prolonged QT interval
use w/ drugs that inhibit CYP enzymes
common 5HT3 antagonists
“setron”
ondansetron
granisetron
dolasetron
palonosetron
antimuscarinics uses
motion sickness
PONV
antimuscarinics adverse effects
dry mouth
blurry vision
cognitive impairment
common antimuscarinic for PONV
scopalamine patch
D2 receptor antagonist MOA
block D2 receptor in CTZ
D2 receptor antagonist adverse effects
acute dystonic reaction
prolonged QT
D2 receptor antagonist common drugs
“peridol”
droperidol
haloperidol
“azine”
perphenazine
promethazine
prochlorperazine
Neurokinin receptor antagonists MOA
inhibits substance P
Neurokinin receptor antagonist drug
Aprepitant
dexamethasone adverse effects
perineal burning, impaired glucose tolerance
Class IA antiarrhythmics
Quinidine
Procainamide
Disopyramide
Class IA antiarrhythmics MOA
block VG Na+ and VG K+ in myocytes
quinidine indications
PVC’s
Systained VT/VF
Afib/Aflutter
short QT syndrome
quinidine adverse effects
N/V
diarrhea
tinnitus/hearing loss
hypotension
QRS & QT prolongation, torsades
quinidine contraindications
prolonged QT
Procainamide Indications
sustained VT, Afib in WPW
procainamide adverse effects
rash, myalgia, vasculitis, hypotension, bradycardia, QT prolongation, torsades, drug induced lupus
Procainamide Contraindications
prolonged QT
disopyramide indications
PVC’s, VT
Afib
dispyramide adverse effects
urinary retention, constipation, glaucoma, QT prolongation, torsades
disopyramide contraindications
prolonged QT
Class IB Antiarrhythmics
Lidocaine
Mexiletine
Class IB Antiarrhythmics MOA
block VG Na+ in myocytes
Class IB Antiarrhythmics indications
V tach, V fib
Class IB Antiarrhythmics adverse effects
increased potency in ischemic tissue, GI effects
lidocaine SE
visaul disturbances
tremor
seizure
drowsiness
hallucination/coma
asystole
hypotension
N/V
Mexiletine SE
GI upset
N/V
blurred vision
tremor
headache
ataxia
confusion
Class IB Antiarrhythmics contraindications
atrial tachyarrhythmias, HF/liver disease
Class IC antiarrhythmics
Flecainide, Propafenone
Class IC antiarrhythmics MOA
dramatically prolong phase 0 in myocyte AP (block VG NA+)
Class IC antiarrhythmics indications
AFib (w/o CAD), SVT
flecainamide adverse effects
dizziness, dyspnea, headache, blurred vision, nausea, HF exacerbation, AV block, VT/VF in pt’s with CAD
flecainamide contraindications
heart failure
CAD
propafenone adverse effects
dizziness, dyspnea, headache, blurred vision, nausea, bradyccardia
bronchospasm
propafenone contraindications
heart failure
CAD
asthma
Class II antiarrhythmic drugs
beta blockers
beta blockers MOA
decreased slope of phase 4 depolarization
prolong depolarization at AV node
beta blocker indications
Afib/Aflutter (slow HR down)
SVT’s
ventricular arrhythmia prevention
will not convert back into normal sinus
beta blocker adverse effects
fatigue
hypotension
bronchospasm
mask hypoglycemic symptoms
aggravation of heart failure
Class III antiarrhythmics
Amiodarone
Class III MOA
K+ blocker
– prolongs QT interval
Class III SE
torsades the pointes
higher proarryhthmia risk
Amiodarone MOA
K+ blocker (high)
- prolongs AP duration
- phase 3
Na+ blocker
Ca2+ blocker
beta blocker (slow SA/AV conduction)
when does amiodarone work best?
at high heart rates due to use-dependence
amiodarone indications
VT/VF
SVT
Afib/Aflutter
amiodarone features
lg volume of distribution due to lipophilicity
requires loading dose (10g)
delayed onset
long half life (2 months)
amiodarone adverse effects
pulmonary toxicity
liver injury
hypotension
bradycardia
AV block
worsening dysrhthmias
thyroid abnormalities
amiodarone contraindications
hypersensitivity (iodine)
cardiogenic shock
bradycardia
AV blocks
amiodarone drug interactions
digoxin
warfarin
statins
amiodarone metabolism
hepatic by CYP3A4 and 2C8
amiodarone inhibits
CYP3A4
CYP2C9
P-glycoprotein
Class III drugs that can cause torsades
dofetilide
sotalol
dronedarone compared to amiodarone
less efficacy than amiodarone
does not contain iodine
dronedarone SE
GI impacts
dronedarone indications
atrial flutter
afib
Class IV antiarrhythmics
non-DHPR CCB’s
verapamil
diltiazem
non-DHPR CCB MOA
inhibition of L-type Ca2+ channels (phase 0 in nodal tissue)
slow depolarization in pacemaker cells
non-DHPR CCB indications
SVT
Afib/Aflutter
non-DHPR CCB adverse effects
hypotension
bradycardia
AV block
decreased SV
adenosine adverse effects
dyspnea
bronchospasm
flushing
chest pressure
Adenosine indications
SVT
digoxin MOA
increases parasympathetic tone via vagus nerve
– decr sinus node
– prolongs AV node refractory
inhibits Na/K-ATPase pump
–incr Ca2+
–incr contractility
–incr proarrhythmic potential
digoxin indications
atrial fibrillation
aflutter
heart failure w/ reduced EF
digoxin CI
afib
aflutter
WPW
digoxin adverse effects
narrow therapeutic window
GI upset
halo vision
malaise
bradycardia
AV block
VT/VF
when is digoxin used?
on a resting heart rate
– pt is just sitting not walking around
rate control in combination with BB/CCB
Antimuscarinics indications
bradycardia
AV block
antimuscarinic side effects
dry mouth
blurry vision
photophobia
tachycardia
antimuscarinic drugs
atropine
glyco
antimuscarinic MOA
block ACH from binding to muscarinic receptors
alters parasympathetic response
anti-parasympathetic drugs
preop causes of volume derangements
bowel preps
bowel obstruction
pancreatitis
blood loss
anesthetic causes of volume derangements
anesthetic hypotension
(vasodilation)
sympathetic blockade
surgical causes of volume derangements
hemorrhage
coagulopathy
decreased venous return
long operative time
when is hypervolemia clincally significant
> 10% above basewline
hypervolemia SE
incr morbidity
tissue edema
impaired wound healing
pulm edema
decr GI motility
what lab value reflects total body water status
serum sodium
what content in IV fluid dictates fluid distribution?
Na+
what factors influence total body water content
gender
age
nutritional status
disease state
TBW and age relationship
less water with increased age
neonates TBW
70-80% of body weight is water
calculating TBW
50-60% of body weight
ICF:ECF
2:1
2/3 ICF and 1/3 ECF
ECF
interstitial fluid (3)
plasma (1)
ISF: plasma = 3:1
electrolyte content of ECF
Na+
Cl-
electrolyte content of ICF
K+
Phosphate
what is colloid osmotic pressure
pulls fluid into vessels
what maintains fluid components of blood within vessels?
colloid osmotic pressure (oncotic pressure)
what changes oncotic pressure
allbumins
proteins
etc
what is hydrostatic pressure
pushes fluid out of vessels
what is osmolar force
push and pull in and out of vessels
what does lactate do in LR?
provides circulating bicarb to provide normal HCO3- levels during acidosis
???????
what is the main contributor of osmolarity
sodium
Tonicity of Crystalloids
isotonic
Distribution of water
ECF and ICF
distribution of saline/LR
distributes only to ECF
distribution of colloids
distributes only to intravascular space
colloid types
albumin
hetastarch
dextrans
HES SE
acute kidney
incr moprtaloity
incr need to PRBC transfusion
albumin
source of capillary oncotic pressure (80%)
types of albumin
hyperoncotic (25%)
5% albumin (isotonic to plasma)
pts low in albumin
nutritionally deficient
renal disease
liver disease
most potent colloid
25% albumin
Hetastarches (HES)
amylopectin and synthetic glycogen
HES molecular weight
high MW = slower degradation